ANN WORDEKEMPER: Open Payments
NPI 1508843681 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 25 payments from 10 companies in 2025. Trend: 2023 $524 · 2024 $551 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $171 |
| PFIZER INC. | 3 | $58 |
| Stryker Corporation | 1 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: VRAYLAR, QULIPTA, VARIAX, UBRELVY, MOUNJARO, VYNDAQEL, ELIQUIS, REXULTI.
Industry payments across IA — which companies pay providers there.
